Free Trial

Xylem Inc. (NYSE:XYL) Stake Boosted by BNP PARIBAS ASSET MANAGEMENT Holding S.A.

Xylem logo with Business Services background

BNP PARIBAS ASSET MANAGEMENT Holding S.A. boosted its holdings in Xylem Inc. (NYSE:XYL - Free Report) by 4.0% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 881,697 shares of the industrial products company's stock after purchasing an additional 34,233 shares during the quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. owned approximately 0.36% of Xylem worth $119,056,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in XYL. EverSource Wealth Advisors LLC grew its position in shares of Xylem by 68.8% during the 1st quarter. EverSource Wealth Advisors LLC now owns 189 shares of the industrial products company's stock valued at $25,000 after buying an additional 77 shares during the last quarter. Bangor Savings Bank raised its position in shares of Xylem by 56.7% during the 3rd quarter. Bangor Savings Bank now owns 235 shares of the industrial products company's stock worth $32,000 after purchasing an additional 85 shares during the period. Mark Sheptoff Financial Planning LLC bought a new stake in shares of Xylem in the 2nd quarter worth approximately $33,000. Blue Trust Inc. boosted its position in Xylem by 1,185.7% during the 2nd quarter. Blue Trust Inc. now owns 270 shares of the industrial products company's stock valued at $35,000 after purchasing an additional 249 shares during the period. Finally, Assetmark Inc. increased its position in Xylem by 3,887.5% in the third quarter. Assetmark Inc. now owns 319 shares of the industrial products company's stock worth $43,000 after buying an additional 311 shares during the period. Institutional investors own 87.96% of the company's stock.

Xylem Trading Up 0.5 %

Shares of XYL stock opened at $122.84 on Thursday. The stock has a 50-day simple moving average of $130.33 and a 200 day simple moving average of $134.46. The stock has a market capitalization of $29.84 billion, a P/E ratio of 35.92, a P/E/G ratio of 2.25 and a beta of 1.05. Xylem Inc. has a fifty-two week low of $100.46 and a fifty-two week high of $146.08. The company has a quick ratio of 1.42, a current ratio of 1.96 and a debt-to-equity ratio of 0.19.

Xylem (NYSE:XYL - Get Free Report) last posted its quarterly earnings data on Thursday, October 31st. The industrial products company reported $1.11 earnings per share for the quarter, meeting the consensus estimate of $1.11. Xylem had a net margin of 9.85% and a return on equity of 9.61%. The company had revenue of $2.10 billion during the quarter, compared to analyst estimates of $2.17 billion. During the same quarter last year, the firm posted $0.99 EPS. The business's revenue for the quarter was up .2% on a year-over-year basis. On average, sell-side analysts expect that Xylem Inc. will post 4.23 earnings per share for the current fiscal year.

Xylem Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 24th. Stockholders of record on Tuesday, November 26th will be given a dividend of $0.36 per share. The ex-dividend date is Tuesday, November 26th. This represents a $1.44 dividend on an annualized basis and a dividend yield of 1.17%. Xylem's dividend payout ratio (DPR) is presently 42.11%.

Analyst Upgrades and Downgrades

Several research firms have recently commented on XYL. UBS Group began coverage on shares of Xylem in a research report on Tuesday, August 13th. They set a "buy" rating and a $165.00 price target for the company. Robert W. Baird decreased their target price on shares of Xylem from $175.00 to $154.00 and set an "outperform" rating for the company in a research report on Friday, November 1st. TD Cowen cut their price target on Xylem from $138.00 to $125.00 and set a "hold" rating on the stock in a report on Wednesday, November 6th. Royal Bank of Canada decreased their price objective on Xylem from $163.00 to $162.00 and set an "outperform" rating for the company in a report on Friday, November 1st. Finally, Stifel Nicolaus lifted their target price on Xylem from $170.00 to $172.00 and gave the company a "buy" rating in a research note on Wednesday, July 31st. Four investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $147.17.

Get Our Latest Analysis on Xylem

About Xylem

(Free Report)

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

See Also

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

→ Trump won. Buy this coin now. (From Weiss Ratings) (Ad)

Should you invest $1,000 in Xylem right now?

Before you consider Xylem, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.

While Xylem currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again
Palantir and the NASDAQ 100: What’s the Next Big Stock Swing for This AI Giant?
Rocket Lab Stock Explodes Higher—What’s Next for This Space Pioneer?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines